|
|
Devon A. Lawson, Owen N. Witte
J Clin Invest. 2007;
117(8):2044
doi:10.1172/JCI32810
Abstract |
Full text
| PDF
P
eter Nowell and David Hungerford’s discovery of the Philadelphia chromosome facilitated many critical studies that have led to a paradigm shift in our understanding of cancer as a disease of stem cells. This Review focuses on the application of these concepts to investigation of the role of stem cells in prostate cancer initiation and progression. Major strides in the development of in vitro and in vivo assays have enabled identification and characterization of prostate stem cells as well as functional evaluation of the tumorigenic effects of prostate cancer–related genetic alterations.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(42)
| Title and authors |
Publication |
Year |
Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer Initiation
Nahyun Choi, Boyu Zhang, Li Zhang, Michael Ittmann, Li Xin
|
Cancer Cell
|
2012 |
Prostate cancer stem cells and their potential roles in metastasis
Hangwen Li, Dean G. Tang
|
J. Surg. Oncol.
|
2011 |
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Naomi L. Dunning, Stéphanie A. Laversin, Amanda K. Miles, Robert C. Rees
|
Cancer Immunol Immunother
|
2011 |
Androgen receptor roles in benign and malignant prostate disease
Juan Wang, Zhi-qun Shang, Yuan-jie Niu
|
Clin. Oncol. Cancer Res.
|
2011 |
Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk
Wen-Yang Hu, Guang-Bin Shi, Dan-Ping Hu, Jason L. Nelles, Gail S. Prins
|
Molecular and Cellular Endocrinology
|
2011 |
Targeting the cancer initiating cell: The Achilles’ heel of cancer
James A. McCubrey, William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Jacquelyn M. Long, Jennifer A. Sattler, C. Ruth Kempf, Piotr Laidler, Linda S. Steelman
|
Advances in Enzyme Regulation
|
2011 |
Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
Adrian P. Rybak, Lizhi He, Anil Kapoor, Jean-Claude Cutz, Damu Tang
|
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
|
2011 |
Chemopreventive effects of tea in prostate cancer: Green tea versus black tea
Susanne M. Henning, Piwen Wang, David Heber
|
Mol. Nutr. Food Res.
|
2011 |
FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells
Masashi Kobayashi, Yanqing Huang, Chengliu Jin, Yongde Luo, Tetsuji Okamoto, Fen Wang, Wallace L. McKeehan
|
Prostate
|
2011 |
Expression analysis of putative stem cell markers in human benign and malignant prostate
Andrey V. Ugolkov, Laurie J. Eisengart, Chunyan Luan, Ximing J. Yang
|
Prostate
|
2011 |
|
